RxSight’s (RXST) Underweight Rating Reiterated at JPMorgan Chase & Co.
JPMorgan Chase & Co. reissued their underweight rating on shares of RxSight (NASDAQ:RXST – Free Report) in a report issued on Friday, Marketbeat Ratings reports. JPMorgan Chase & Co. currently has a $17.00 price target on the stock, down from their prior price target of $40.00. RXST has been the subject of a number of […]
JPMorgan Chase & Co. reissued their underweight rating on shares of RxSight (NASDAQ:RXST – Free Report) in a report issued on Friday, Marketbeat Ratings reports. JPMorgan Chase & Co. currently has a $17.00 price target on the stock, down from their prior price target of $40.00. RXST has been the subject of a number of […]
